Humana Inc.

NYSE:HUM

Medical - Healthcare Plans

Healthcare
$385.71 +0.19%

+$0.70 today

Market cap
$46.32B
Beta
0.77
P/E (TTM)
38.6
EPS (TTM)
$9.39
Dividend yield
0.98%
52W Low $163.11High $380.86

Volume 4.06M

Average 1.72M

HUM Interest Expense

Cost of servicing the company's debt during the period.

Humana Inc.NYSE: HUM

Interest Expense · Q3 FY2026 · quarter ended Sep 2026

Interest expense growth accelerates

Q3 FY2026 interest expense of $217M rose 29.2% year over year, ahead of the +16.0% change in trailing-twelve-month interest expense. Sequentially, it rose 10.2% from the prior quarter. Over 3 fiscal years it compounded at +16.3% a year.

Context

  • Interest expense amounted to 0.5% of revenue in FY2025, unchanged from a year earlier.
  • Interest expense increased in 2 of the last 3 fiscal years.

What to watch

Whether quarterly growth of +29.2% holds above the trailing-twelve-month pace of +16.0%.

Sources:Income StatementText generated from reported figures; not investment advice.

Latest quarterSep 2026
$217M+10.2% QoQ
Last fiscal yearDec 2025
$631M-4.4% YoY
LTMSep 2026
$753M+16.0% YoY
Interest Expense past and forecast growth by horizon
Horizon Past Forecast Difference
Quarter+29.2%——
1 year-4.4%——
3-year CAGR+16.3%——
5-year CAGR——
10-year CAGR——

Interest Expense history

USD · from the income statement

Latest · FY2025
631M USD
Year-over-year change
-4.4%
4-year CAGR
+18.0%

Interest Expense vs competitors

How HUM compares with its peers on the latest reported figures

  • HUM's LTM Sep 2026 interest expense of $753M is the 5th highest of the 9 companies compared; the peer median is $896M.
  • Its year-over-year change of +16.0% is the 2nd highest of 9, against a peer median of -4.6%.
  • Interest expense amounts to 0.5% of revenue for HUM, versus a peer median of 0.5%.
HUM Competitors Peer median
Interest Expense for HUM and competitors
Company Period LTM YoY 3-year CAGR% of revenue
UNHUnitedHealth Group IncorporatedLTM Sep 2026$3.85B -4.4%+24.1%0.9%
CVSCVS Health CorporationLTM Jun 2026$3.1B +1.4%+10.9%0.7%
CICigna CorporationLTM Sep 2026$1.38B -1.9%+4.0%0.5%
ELVElevance Health Inc.LTM Sep 2026$1.14B -17.4%+18.1%0.6%
HUMHumana Inc.LTM Sep 2026$753M +16.0%+16.3%0.5%
CNCCentene CorporationLTM Jun 2026$655M -4.8%+0.6%0.3%
MOHMolina Healthcare, Inc.LTM Sep 2026$213M +22.4%+20.4%0.5%
ALHCAlignment Healthcare, Inc.LTM Mar 2026$15.91M -27.9%-4.8%0.4%
OSCROscar Health, Inc.LTM Jun 2026$15.85M -33.1%-8.0%0.1%
Peer median (excluding HUM) $896M-4.6%+7.4%0.5%

Competitors are the stored peer set for HUM. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue83.65B92.92B106.44B117.81B129.66B
Cost of Revenue69.2B75.69B88.39B100.66B110.81B
Gross Profit14.45B17.23B18.05B17.15B18.85B
Gross Margin17.3%18.5%17.0%14.6%14.5%
Research & Development00000
Selling, General & Admin00000
Operating Expenses11.03B13.67B14.73B15.52B17.4B
Depreciation & Amortization713M845M917M968M824M
EBITDA4.46B4.81B4.73B3.26B2.91B
EBITDA Margin5.3%5.2%4.4%2.8%2.2%
Operating Income3.42B3.56B3.32B1.63B1.45B
Operating Margin4.1%3.8%3.1%1.4%1.1%
Interest Income00000
Interest Expense326M401M493M660M631M
Other Income / Expenses00000
Income Before Tax3.42B3.56B3.32B1.63B1.45B
Pre-Tax Margin4.1%3.8%3.1%1.4%1.1%
Income Tax Expense485M762M836M413M250M
Net Income2.93B2.81B2.49B1.21B1.19B
Net Margin3.5%3.0%2.3%1.0%0.9%
EPS (Basic)22.7922.2020.0910.019.87
EPS (Diluted)22.6722.0820.009.989.84
Weighted Avg Shares128.69M126.42M123.87M120.57M120.45M
Weighted Avg Shares (Diluted)129.4M127.09M124.44M120.87M120.83M

Humana Inc.

NYSE:HUM

Intrinsic Alpha fair value

Locked

Current Price

$385.71

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.